Antihyperglycemic activity of Swertia chirayita and Andrographis paniculata plant extracts in streptozotocin-induced diabetic rats

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 3, 2013, Pages 305-311

  Verma, Vinod Kumar ^a   Kumar Sarwa, Khomendra ^a   Zaman, Md Kamaruz ^a  

^a DIBRUGARH UNIVERSITY   (India)

Author keywords

Andrographis paniculata; Antihyperglycemic; Streptozotacin; Swertia chirayita

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; GLIBENCLAMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; STREPTOZOCIN;

ACUTE TOXICITY; ANDROGRAPHIS PANICULATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CHEMICAL ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; EXTRACTION AND EXTRACTS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; SWERTIA CHIRAYITA; UREA NITROGEN BLOOD LEVEL;

EID: 84879926999     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care1998; 21: 1414-1431.
2. Yajnik CS. The insulin resistance epidemic in India: fetal origins, later lifestyle, or both? Nutr. Rev. 2001: 59, 1-9.
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
4. Chakraborty R, Vikramadithyan R K, Mullangi R, Sharma V M, Jagadheshan H, Rao Y, et al., Hypoglycemic and hypolipidemic activity of Helicteres isora in animal models. J. Ethnopharmacol. 2002; 81: 343-349.
5. Kameswara Rao B, Kesavulu MM, and Apparao C. Evaluation of hypoglycemic effect of Momordica cymbalaria fruit in alloxan-diabetic rats. Fitoterapia 2003a; 74: 7-13.
6. Lillioja, S, Mott DM, Howard V, Bennett PH, Hannele YJ, Freymond D. Impaired glucose tolerance as a disorder of insulin action: longitudinal and crosssectional studies in Pima Indians. North England Journal of Medicine 1988; 318:1217-1224.
7. O'Rahilly S, Turner RC, Matthews DR. Impaired pulsatile secretion of insulin in relatives of patients with noninsulin-dependent diabetes. North England Journal of Medicine 1988;318:1225-1230.
8. Matthaei S, Stumvoll M, Kellerer M, Haring H. Pathophysiology and pharmacological treatment of insulin resistance. Endocrine Reviews 2000; 21: 585-618.
9. Pepato MT, Mori DM, Baviera AM, Harami JB, Vendramini RC, Brunetti IL. Fruit of the Jambolan tree (Eugenia jambolana Lam.) and experimental diabetes. J Ethnopharmacol 2005; 96:43-8.
10. Rang HP, Dale MM. The Endocrine System Pharmacology, second ed. Longman Group Ltd., United Kingdom 1991; pp. 504-508.
11. Venkatesh S, Reddy GD, Reddy BM, Ramesh, M, Appa Rao, AVN. Antihyperglycemic activity of Caralluma attenuata. Fitoterapia 2003; 74: 274-279.
12. Marles RJ, Farnsworth N. Antidiabetic plants and their active constituents. Phytomedicine 1995; 2(2):137-189.
13. Suba V, Murugesan T, Arunachalam G, Mandal SC, Saha BP. Anti-diabetic potential of Barleria lupulina extract in rats. Phytomedicine 2004a; 11: 202-205.
14. Hepcy KD, Dinakar A, Senthil KN. Evaluation of anti-diabetic activity of ethanolic and aqueous extracts of stem and leaves of Alangium salvifolium and Pavonia zeylanica. Int J Pharm Pharm Sci 2013; 5(2): 363-366.
15. Pari L, Umamaheswari J. Antihyperglycaemic activity of Musa sapientum flowers: effect on lipid peroxidation in alloxan diabetic rats. Phytother. Res. 2000; 14: 1-3.
16. Saini S, Sharma S. Antidiabetic effect of Helianthus annuus L., seeds ethanolic extract in Streptozotocin-nicotinamide induced type 2 diabetes mellitus. Int J Pharm pharm Sci 2013; 5(2): 382-387
17. Karan M, Vasisht K, Handa SS. Morphological and chromatographic comparison of certain Indian species of Swertia. J. Med. Aromatic Plant Sci, 1997;19: 955-963.
18. Hase K, Li J, Basnet P, Xiong Q, Takamura S, Namba, T, Kadota S. Hepatoprotective principles of Swertia japonica MAKINO on D-Galactosamine/Lipopolysaccharide-induced liver injury in mice. Chem. Pharm. Bull. 1997; 45: 1823-1827.
19. Karan M, Vasisht, K, Handa S S. Antihepatotoxic activity of Swertia chirata on paracetamol and galactosamine-induced hepatotoxicity in rats. Phytother. Res. 1999; 13: 95-101.
20. Bajpai M B, Asthana RK, Sharma NK. Chatterjee SK, Mukherjee S, Hypoglycemic effect of swerchirin from the hexane fraction of Swertia chirayita. Planta Med. 1991; 57: 102-104.
21. Saxena AM, Bajpai MB, Mukherjee SK. Swerchirin induced blood sugar lowering of streptozotocin treated hyperglycemic rats. Indian J. Exp. Biol. 1991; 29: 674-675.
22. Ya, B Q, Nian LC, Li C, Gen X P. Protective effect of swerchirin on hematopoiesis in 60Co-irradiated mice. Phytomedicine 1999; 6: 85-88.
23. Chadha Y., The Wealth of India: Raw Materials, vol. 1A. Council of Scientific and Industrial Research, New Delhi, India, 1985;pp. 264.
24. Matsud, T, Kuroyanangi M, Sygiyama S, Umehara K, Ueno A, Nishi K. Cell differentiation-inducing diterpenes from Andrographis paniculata. Chem. Pharmacol. Bull. 1994; 42: 1216-1225.
25. Handa SS, Sharma A. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbontetrachloride. Ind. J. Med. Res. 1990; 92 (B): 276-283.
26. Singh U, Wadhwani AM, John BM. Andrographis paniculata. Dictionary of Economic Plants in India, second ed. Indian Council of Agricultural Research, New Delhi, 1983; pp. 16.
27. Murugian P, Palanisamy M, Stanley A, Akbarsha MA. Prospective use of andrographolide in male antifertility. In: International Symposium on Male Contraception Present and Future, New Delhi, India,1995; pp. 34-35.
28. Saxena S, Jain DC, Gupta MM, Bhakuni RS, Mishra HO, Sharma RP. High performance thin layer chromatographic analysis of hepatoprotective dilerpenoids from Andrographis paniculata. Phytochem. Anal. 2000;11: 34-36.
29. Tipakorn N. Effects of Andrographis paniculata (Burm.F.) Nees on performance, mortality and coccidiosis in broiler chickens. Ph.D. thesis. Institute of Animal Physiology and Animal Nutrition, Georg-August-Universitat, Gottingen. 2002.
30. Otake T, Mori H, Morimoto LT, Hattori M, Namba T. Screening of Indonesian plant extracts for anti human immunodeficiency virus-type 1 (HIV-1) activity. Phytother. Res. 1995; 9: 6-10.
31. Saraswat B, Visen P, Patanik GK, Dhawan BN. Effect of andrographolide against galaetosamine-induced hepatotoxicity. Fitoterapia 1995; 66:415-420.
32. Misra P, Pal NL, Guru PY, Katiyar JC, Srivastava V, Tandon JS. Antimalarial activity of Andrographis paniculata (Kalmegh) against plasmodium berghei NK 65 in Mastomys natatensis. Int. J. Pharmacogenomics 1992; 30: 263-274.
33. Kapil A, Koul IB, Banerjee SK, Gupta BD. Antihepatotoxic effects of major diterpenoids constituents of Andrographis paniculata. Biochem. Pharmacol. 1993; 46:182-185.
34. Organization for Economic Cooperation and Development (OECD). OECD Guideline for Testing of Chemicals (Internet) France: OECD Publishing; 2006 July11. Section 4, Health Effects: Test No.425: Acute Oral Toxicity: Up and Down Procedure; 2006 p.1-27. Available from: http//www.oecdbookshop.org/oecd/index.asp/langen. (Adopted 2006 Mar 23, cited 2009 Mar 22).
35. Chattopadhyay RR. A comparative evaluation of some blood sugar lowering agents of plant origin. J Ethanopharmacol 1999; 67:367-372.
36. Babu V, Gangadevi T, Subramonium A. Antidiabetic activity of ethanol extract of Cassia kleinii leaf in streptozotocine-induced diabetic rats and isolation of an active fraction and toxicity evaluation of the extract. Indian J Pharmacol 2003;35:290-296.
37. Chattopadhyay RR. Hypoglycemic effect of Ocimum sanctum leaf extract innormal and streptozotocin diabetic rats. Indian J Exp Biol 1993; 31:891-893.
38. Jung HW, Jung JK, Ramalingam M, Yoon CH, Bae HS, Park YK. Antidiabetic effect of Wen-pi-tang-Hab-Wu-Ling-san extract in streptozotocin-induced diabetic rats, Indian J Pharmacology 2012;44(1):97-102.
39. thed. New Delhi: Jaypee Publication 2003.
40. Frememisoglu A, Kelestimur F, Kokel AH, Utsun H, Telok Y, Ustdal M. Hypoglycemic effect of Zizyphus jujube leaves. J. Pharm Pharmacol. 1995; 47:72-74.
41. Grover JK, Vats U, Yadav S. Effect of feeding aqueous extract of Petrocarpus merscupium on glycogen content of the tissues and the key enzyme of carbohydrate metabolism. Molecular Celluar Biochemistry 2002; 241:53-59.
42. Rao YK, Vimalamma G, Rao CV, Tzeng YM. Flavonoids and andrographolides from Andrographis paniculata. Phytochemistry 2004; 65: 2317-2321.
43. Brenna O, Qvigstad G, Brenna E, Waldum HL. Cytotoxicity of streptozotocin on neuroendocrine cells of the pancreas and the gut. Dig Dis Sci 2003; 48:906-10.
44. Haaiwell B, Gudtteridge JM. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1994; 344:1396-1397.
45. Kawalali G, Tuncel H, Goksel S, Hatemi HH. Hypoglycemic activity of Urtica pilulifera in streptozotocin diabetic rats. J Ethanopharmacol. 2002; 84: 241-245.
46. thed. Philadelphia; WB Saunders; 1996.
47. Kamanna VS, ROh DD, Krischenbaum MA. Hyperlipidmoia amd kidney disease: Concept derived from histopathology of the glomerulus. Histol Histopathol 1998; 13:169-179.
48. Bach JF. Autoimmunity and type I diabetes. Trends Endocrinol Metab 1997; 8:71-78.
49. Elsner M, Guldbakke B, Tiedge M, Nundy R, Leszen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetlogia 2000; 43:2528-1533.
50. Fujitani S, Ikenous T, Akiyoshi M, Maki T, Yada T. Somatostin and insulin secretion due to common mechanism by a new hypoglycemic agent A-4166, in perused rat pancreas. Metabolism 1996; 45:184-189.
51. 2+) oscillation in mouse pancreatic islets. Biochem Pharmacol 2001; 62:923-928.
52. Suryawanshi NP, Bhutey AK, Nagdeote AN, Jadhav AA, Manoorkar GS. Study of lipid peroxide and lipid profile in diabetes mellitus. Indian J Clin Biochem 2006; 21:126-130.
53. Abbate SL, Brunzell JD. Pathophisiology of hyperlipidemia in diabetes mellitus. J Cardiovasc Pharmacol 1990; 16S:1-7.
54. Wanner C, Greiber S, Kramer-Guth A, Heinloth A, Galle J. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein (a). Kidney Int 1997; 63S:102-106.
55. Baquer NZ, Gupta D, Raju J. Regulation of metabolic pathways in liver and kidney during experimental diabetes: effects of antidiabetic compounds. Indian J Clin Biochem 1998; 13:63-80.
56. Hadjadj S, Duly-Bouhanik B, Bekherraz A, Bridoux F, Gallois Y, Mauco G, et al., serum triglyceride are a predictive factor for the development and the progression of renal and retinal complication in patient with type I diabetes. Diabetes Metab 2004;30:43-51.
57. thed. Philadelphia: NB Saunders Company; 1996. pp. 312-335.
58. Almdal JP, Vilstrup H. Strict Insulin therapy normalizes organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats. Diabetologia 1998;31:114-118.